Avalo Therapeutics, Inc.
SEC Filing List
AVTX CIK: 0001534120
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | Allen Overy Shearman Sterling LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | SHARTSIS FRIESE LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G | 05/15/2026 | ||||
| SCHEDULE 13G/A | OLSHAN FROME WOLOSKY LLP /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | AKIN GUMP STRAUSS HAUER & FELD LLP LOS ANGELES OFFICE /FA/ | 05/14/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Avalo Therapeutics, Inc. | 05/13/2026 | ||
| 8-K | Current report filing | Avalo Therapeutics, Inc. | 05/13/2026 | ||
| No record found. | |||||
| Load More | |||||
